alexa Biosimilar Products: Application in Advanced Drug Thera
ISSN: 2168-9784

Journal of Medical Diagnostic Methods
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Biosimilar Products: Application in Advanced Drug Therapy: A Qualitative Insight

Sadia Shakeel1*, Wajiha Iffat1 and Hafiza Fouzia Ahmed2
1Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan
2Jinnah University for Women, Karachi, Pakistan
Corresponding Author : Sadia Shakeel
Dow College of Pharmacy
Dow University of Health Sciences
Karachi-75270, Pakistan
Tel: 6595229237
E-mail: [email protected]
Received: November 23, 2015; Accepted: January 27, 2016; Published: February 01, 2016
Citation: Shakeel S, Iffat W and Ahmed HF (2016) Biosimilar Medicines and their Use: The Study Assessing Health Experts’ Views. J Med Diagn Meth 5:199. doi:10.4172/2168-9784.1000199
Copyright: © 2016 Shakeel S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


This exploratory, descriptive study aims to explore general practitioners’ viewpoint about biosimilar drugs, conducted on a sample of 128 randomly selected general practitioners serving in public sector hospitals in Karachi, Pakistan. They were surveyed with a 12 items questionnaire that evaluates their approach towards biosimilar drugs. The collected data was analyzed for frequency distributions and χ2 using SPSS. The present findings highlight a need for further education of physicians and others related to the prescribing of biosimilar medicines as poor knowledge could result in serious medication errors, adverse events or a delay in desired therapeutic gain for the patient. Further dialogue and collaboration between physicians, authorities and healthcare biotech industry should be continued on a priority basis.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version